Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Aggression × Rituximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 236 Lymphoma, Large B-Cell, Diffuse 226 Leukemia, Lymphocytic, Chronic, B-Cell 168 Lymphoma, Non-Hodgkin 162 Lymphoma, Mantle-Cell 145 Lymphoma, Follicular 142 Lymphoma, B-Cell, Marginal Zone 97 Leukemia 87 Burkitt Lymphoma 75 Precursor Cell Lymphoblastic Leukemia-Lymphoma 74 Waldenstrom Macroglobulinemia 73 Lymphoma, B-Cell 48 Hodgkin Disease 48 Recurrence 46 Lymphoma, Large-Cell, Immunoblastic 40 Leukemia, Myeloid, Acute 20 Myelodysplastic Syndromes 18 Lymphoma, Large-Cell, Anaplastic 16 Intraocular Lymphoma 14 Hematologic Neoplasms 14 Dendritic Cell Sarcoma, Interdigitating 14 Multiple Myeloma 13 Neoplasms 12 Leukemia, Hairy Cell 12 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Neoplasms, Plasma Cell 10 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Leukemia, Prolymphocytic 9 Leukemia, Myelomonocytic, Chronic 9 Leukemia, Myeloid, Accelerated Phase 9

Interventions

selinexor 1 pegfilgrastim 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡